tiprankstipranks
Trending News
More News >
Cantor upgrades Fulcrum to Overweight on sickle cell opportunity
PremiumThe FlyCantor upgrades Fulcrum to Overweight on sickle cell opportunity
1M ago
Fulcrum Therapeutics upgraded to Overweight from Neutral at Cantor Fitzgerald
Premium
The Fly
Fulcrum Therapeutics upgraded to Overweight from Neutral at Cantor Fitzgerald
1M ago
Oppenheimer biotech analyst holds an analyst/industry conference call
Premium
The Fly
Oppenheimer biotech analyst holds an analyst/industry conference call
2M ago
Fulcrum Therapeutics price target lowered to $12 from $14 at Oppenheimer
PremiumThe FlyFulcrum Therapeutics price target lowered to $12 from $14 at Oppenheimer
2M ago
Fulcrum Therapeutics reports Q1 EPS (28c) vs. (43c) last year
Premium
The Fly
Fulcrum Therapeutics reports Q1 EPS (28c) vs. (43c) last year
2M ago
Fulcrum Therapeutics sees cash runway into at least 2027
Premium
The Fly
Fulcrum Therapeutics sees cash runway into at least 2027
2M ago
Sell Rating on Fulcrum Therapeutics Due to Uncertain Prospects and Financial Concerns
PremiumRatingsSell Rating on Fulcrum Therapeutics Due to Uncertain Prospects and Financial Concerns
4M ago
Fulcrum Therapeutics Reports Strong Financial Position and Progress
Premium
Company Announcements
Fulcrum Therapeutics Reports Strong Financial Position and Progress
4M ago
OpCo reiterates Outperform on Fulcrum given bullish vibes ahead of SCD readout
Premium
The Fly
OpCo reiterates Outperform on Fulcrum given bullish vibes ahead of SCD readout
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100